Company intelligence / Profile preview

SC Liver Research Consortium

Sarasota, Florida, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

SCLRC is a large US-based physician-led clinical site network, specializing in fast, high-quality enrollment and management of Phase I-IV hepatology/gastroenterology/oncology trials. Recent and ongoing projects include late-stage NASH, PBC, liver cancer, and NAFLD studies, with high enrollment performance and participation in studies yielding major advances in liver disease research and therapy outcomes.

Therapeutic areas: OncologyGastroenterologyInfectious Diseases
Modalities: Small moleculeDeviceBiologic
Industry: Academic Hospital/University/Research

Partnerships

Perspectum DiagnosticsScripps HealthUniversity of LouisvilleColorado Medical Society

Beyond the preview

Go deeper on SC Liver Research Consortium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SC Liver Research Consortium.

Explore the full profile